Suite (Excel, Word and PowerPoint) and MS Project. About Alnylam: AlnylamPharmaceuticals (Nasdaq: ALNY) has led the... or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific...
objectives of Alnylam in the designated therapeutic area. The Medical Affairs Manager is expected to be a qualified physician... supporting Alnylam medicines within the scope of the Medical Affairs Manager role. The Medical Affairs Manager (Final Signatory...
Suite (Excel, Word and PowerPoint) and MS Project About Alnylam: AlnylamPharmaceuticals (Nasdaq: ALNY) has led the... or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific...
) and MS Project About Alnylam: AlnylamPharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi... in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture...
) and MS Project. About Alnylam: AlnylamPharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi... in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture...
, and PowerPoint. Ability to travel approximately 10% is required. Demonstrate clear alignment with Alnylam Core Values including..., Commitment to People Fiercely Innovative Purposeful Urgency Open Culture Passion for Excellence. About Alnylam: Alnylam...
the company;capable of representing the company externally About Alnylam: AlnylamPharmaceuticals (Nasdaq: ALNY... and supports the medical objectives of Alnylam in the designated therapeutic area. The Medical Affairs Manager is expected...
The Associate Director in Clinical Pharmacology position will support a rapidly expanding clinical portfolio of promising RNAi therapeutics in CNS. The candidate in this position should be well versed in clinical pharmacology, PK and PD wit...
Job Description: The Associate Director in Clinical Pharmacology position will support a rapidly expanding clinical portfolio of promising RNAi therapeutics in CNS. The candidate in this position should be well versed in clinical pharmaco...
) and MS Project . About Alnylam: AlnylamPharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi... in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture...